Public perspectives on disinvestments in drug funding: results from a Canadian deliberative public engagement event on cancer drugs

Public perspectives on disinvestments in drug funding: results from a Canadian deliberative public engagement event on cancer drugs

Abstract Background Decisions relating to the funding of new drugs are becoming increasingly challenging due to a combination of aging populations, rapidly increasing list prices, and greater numbers of drug-indication pairs being brought to market. This is especially true in cancer, where rapid lis...

Descripció completa

Dades bibliogràfiques
Autors principals: Sarah Costa, Colene Bentley, Dean A. Regier, Helen McTaggart-Cowan, Craig Mitton, Michael M. Burgess, Stuart J. Peacock
Format: Article
Idioma:English
Publicat: BMC 2019-07-01
Col·lecció:BMC Public Health
Matèries:
Priority setting
Cancer drug funding
Disinvestment
Public engagement
Accés en línia:http://link.springer.com/article/10.1186/s12889-019-7303-2

Internet

http://link.springer.com/article/10.1186/s12889-019-7303-2

Ítems similars